Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
An isolated polypeptide comprising the amino acid sequence of serum paraoxonase (PON1) having catalytic efficiency of k cat /K M ≈10 6 -5·10 7 M −1 min −1 for a G-type organophosphate.
1. An isolated polypeptide comprising an amino acid sequence of a variant serum paraoxonase (PON1) selected from the group consisting of SEQ ID NO: 2, 129, 140, 141 and 142, said isolated polypeptide having hydrolase catalytic efficiency of k cat /k M ≈10 6 -5·10 7 M −1 min −1 for a G-type organophosphate.
2. The isolated polypeptide of claim 1 being expressible in bacteria.
3. An isolated synthetic complimentary DNA (cDNA) polynucleotide comprising a nucleic acid sequence encoding the polypeptide of claim 1 .
4. A pharmaceutical composition comprising as an active ingredient the isolated polypeptide of claim 1 and a pharmaceutically acceptable carrier.
5. A nucleic acid construct comprising the isolated synthetic cDNA of claim 3 and a cis-regulatory element driving expression of said polynucleotide.
6. A method of treating an organophosphate exposure associated damage in a subject, comprising administering to the subject a therapeutically effective amount of the isolated polypeptide of claim 1 .
7. An article of manufacture for treating or preventing organophosphate exposure-associated damage, the article of manufacture comprising the isolated polypeptide of claim 1 immobilized on to a solid support.
8. The article of manufacture of claim 7 , wherein said solid support is for topical administration.
9. The article of manufacture of claim 8 , wherein said solid support for topical administration is selected from the group consisting of a sponge, a wipe and a fabric.
10. The article of manufacture of claim 7 , wherein said solid support is selected from the group consisting of a filter, a fabric and a lining.
11. A method of detoxifying a surface, the method comprising contacting the surface with the isolated polypeptide of claim 1 , thereby detoxifying the surface.
12. The isolated polypeptide of claim 1 comprising the amino acid sequence of SEQ ID NO: 140.
13. The isolated polypeptide of claim 1 , comprising SEQ ID NO: 129.
14. The isolated polypeptide of claim 1 , comprising SEQ ID NO: 141.
15. The isolated polypeptide of claim 1 , comprising SEQ ID NO: 142.
16. The isolated polypeptide of claim 1 , comprising SEQ ID NO: 2.